| Ident. | Authors (with country if any) | Title |
|---|
| 000014 |
Guido Alves [Norvège] ; Kenn Freddy Pedersen [Norvège] ; Bastiaan R. Bloem [Pays-Bas] ; Kaj Blennow [Suède] ; Henrik Zetterberg [Suède] ; George F. Borm [Pays-Bas] ; Turi O. Dalaker [Norvège] ; Mona K. Beyer [Norvège] ; Dag Aarsland [Norvège] ; Ulf Andreasson [Suède] ; Johannes Lange [Norvège] ; Ole-Bj Rn Tysnes [Norvège] ; Robert Zivadinov [États-Unis] ; Jan Petter Larsen [Norvège] | Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease |
| 000076 |
T. Foltynie [Royaume-Uni] ; L. Zrinzo [Royaume-Uni] ; I. Martinez-Torres [Espagne] ; E. Tripoliti [Royaume-Uni] ; E. Petersen [États-Unis] ; E. Holl [Royaume-Uni, Autriche] ; I. Aviles-Olmos [Royaume-Uni] ; M. Jahanshahi [Royaume-Uni] ; M. Hariz [Royaume-Uni, Suède] ; P. Limousin [Royaume-Uni] | MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety |
| 000119 |
Magdalena Eriksson Domellöf [Suède] ; Eva Elgh [Suède] ; Lars Forsgren [Suède] | The relation between cognition and motor dysfunction in drug‐naive newly diagnosed patients with Parkinson's disease |
| 000132 |
M. Andersson [Suède] ; H. Zetterberg [Suède] ; L. Minthon [Suède] ; K. Blennow [Suède] ; E. Londos [Suède] | The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia |
| 000166 |
C. Becker [Suisse] ; G. P. Brobert ; S. Johansson [Suède] ; S. S. Jick [États-Unis] ; C. R. Meier [Suisse, États-Unis] | Risk of incident depression in patients with Parkinson disease in the UK |
| 000276 |
Lazlo Horvath [Suède] ; Ingrid Van Marion [Suède] ; Khalid Taï [Suède] ; Troels Tolstrup Nielsen [Danemark] ; Cecilia Lundberg [Suède] | Knockdown of GAD67 protein levels normalizes neuronal activity in a rat model of Parkinson's disease |
| 000284 |
Maria Papathanou [Suède] ; Sarah Rose [Royaume-Uni] ; Andrew Mccreary [Pays-Bas] ; Peter Jenner [Royaume-Uni] | Induction and expression of abnormal involuntary movements is related to the duration of dopaminergic stimulation in 6‐OHDA‐lesioned rats |
| 000287 |
Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] | Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
| 000320 |
T. Archer [Suède] ; A. Fredriksson [Suède] ; B. Johansson [Suède] | Exercise alleviates Parkinsonism: clinical and laboratory evidence |
| 000397 |
Michael A. Van Es [Pays-Bas] ; Helenius J. Schelhaas [Pays-Bas] ; Paul W. J. Van Vught [Pays-Bas] ; Nicola Ticozzi [États-Unis, Italie] ; Peter M. Andersen [Suède] ; Ewout J. N. Groen [Pays-Bas] ; Claudia Schulte [Allemagne] ; Hylke M. Blauw [Pays-Bas] ; Max Koppers [Pays-Bas] ; Frank P. Diekstra [Pays-Bas] ; Katsumi Fumoto [Pays-Bas] ; Ashley Lyn Leclerc [États-Unis] ; Pamela Keagle [États-Unis] ; Bastiaan R. Bloem [Pays-Bas] ; Hans Scheffer [Pays-Bas] ; Bart F. L. Van Nuenen [Pays-Bas] ; Marka Van Blitterswijk [Pays-Bas] ; Wouter Van Rheenen [Pays-Bas] ; Anne-Marie Wills [États-Unis] ; Patrick P. Lowe [États-Unis] ; Guo-Fu Hu [États-Unis] ; Wenhao Yu [États-Unis] ; Hiroko Kishikawa [États-Unis] ; David Wu [États-Unis] ; Rebecca D. Folkerth [États-Unis] ; Claudio Mariani [Italie] ; Stefano Goldwurm [Italie] ; Gianni Pezzoli [Italie] ; Philip Van Damme [Belgique] ; Robin Lemmens [Belgique] ; Caroline Dahlberg [Suède] ; Anna Birve [Suède] ; Rubén Fernández-Santiago [Pays-Bas, Espagne, Allemagne] ; Stefan Waibel [Allemagne] ; Christine Klein [Allemagne] ; Markus Weber [Suisse] ; Anneke J. Van Der Kooi [Pays-Bas] ; Marianne De Visser [Pays-Bas] ; Dagmar Verbaan [Pays-Bas] ; Jacobus J. Van Hilten [Pays-Bas] ; Peter Heutink [Pays-Bas] ; Eric A. M. Hennekam [Pays-Bas] ; Edwin Cuppen [Pays-Bas] ; Daniela Berg [Pays-Bas] ; Robert H. Brown Jr [États-Unis] ; Vincenzo Silani [Italie] ; Thomas Gasser [Allemagne] ; Albert C. Ludolph [Allemagne] ; Wim Robberecht [Belgique] ; Roel A. Ophoff [Pays-Bas, États-Unis] ; Jan H. Veldink [Pays-Bas] ; R. Jeroen Pasterkamp [Pays-Bas] ; Paul I. W. De Bakker [Pays-Bas, États-Unis] ; John E. Landers [États-Unis] ; Bart P. Van De Warrenburg [Pays-Bas] ; Leonard H. Van Den Berg [Pays-Bas] | Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis |
| 000403 |
G-M. Hariz [Suède] ; L. Forsgren [Suède] | Activities of daily living and quality of life in persons with newly diagnosed Parkinson’s disease according to subtype of disease, and in comparison to healthy controls |
| 000448 |
Tomas Bjrklund [Suède] ; Thomas Carlsson [Suède] ; Erik Ahlm Cederfjll [Suède] ; Manolo Carta [Suède] ; Deniz Kirik [Suède] | Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinsons disease |
| 000481 |
Guido Alves [Norvège] ; Kolbj Rn Br Nnick [Norvège] ; Dag Aarsland [Norvège] ; Kaj Blennow [Suède] ; Henrik Zetterberg [Suède] ; Clive Ballard [Royaume-Uni] ; Martin Wilhelm Kurz [Norvège] ; Ulf Andreasson [Suède] ; Ole-Bj Rn Tysnes [Norvège] ; Jan Petter Larsen [Norvège] ; Ezra Mulugeta [Norvège, Royaume-Uni] | CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study |
| 000556 |
Romulo Fuentes [États-Unis] ; Per Petersson [Suède] ; Miguel A. L. Nicolelis [États-Unis, Brésil] | Restoration of locomotive function in Parkinson’s disease by spinal cord stimulation: mechanistic approach |
| 000622 |
Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis] | Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study |
| 000639 |
Britt-Marie Sjölund [Suède] ; Gunilla Nordberg [Suède] ; Anders Wimo [Suède] ; Eva Von Strauss [Suède] | Morbidity and Physical Functioning in Old Age: Differences According to Living Area |
| 000649 |
Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède] | Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia |
| 000676 |
Jan Linder [Suède] ; Hans Stenlund [Suède] ; Lars Forsgren [Suède] | Incidence of Parkinson's disease and parkinsonism in northern Sweden: A population‐based study |
| 000706 |
Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis] | Gene therapy for Parkinson's disease |
| 000714 |
Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] | Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease |
| 000755 |
Arjan W. Braam [Pays-Bas] ; Aartjan T. F. Beekman [Pays-Bas] ; Michael E. Dewey [Royaume-Uni] ; Philippe A. E. G. Delespaul [Pays-Bas] ; Manfred Fichter [Allemagne] ; Antonio Lobo [Espagne] ; Hallgrímur Magnússon [Islande] ; Karine Pérès [France] ; Friedel M. Reischies [Allemagne] ; Marc Roelands [Belgique] ; Pedro Saz [Espagne] ; Robert A. Schoevers [Pays-Bas] ; Ingmar Skoog [Suède] ; John R. M. Copeland [Royaume-Uni] | Depression and parkinsonism in older Europeans: results from the EURODEP concerted action |
| 000766 |
Ayse Ulusoy [Suède] ; Fabia Febbraro [Danemark] ; Poul H. Jensen [Danemark] ; Deniz Kirik [Suède] ; Marina Romero-Ramos [Suède, Danemark] | Co‐expression of C‐terminal truncated alpha‐synuclein enhances full‐length alpha‐synuclein‐induced pathology |
| 000781 |
Jia-Yi Li [Suède] ; Elisabet Englund [Suède] ; H Kan Widner [Suède] ; Stig Rehncrona [Suède] ; Anders Björklund [Suède] ; Olle Lindvall [Suède] ; Patrik Brundin [Suède] | Characterization of Lewy body pathology in 12‐ and 16‐year‐old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease |
| 000923 |
Stefanie Hennig [Suède] ; Joakim Nyberg [Suède] ; Andrew C. Hooker [Suède] ; Mats O. Karlsson [Suède] | Trial Treatment Length Optimization With an Emphasis on Disease Progression Studies |
| 000929 |
P. Hagell [Suède] ; L. Brundin [Suède] | Towards an understanding of fatigue in Parkinson disease |
| 000989 |
Sebastian Palmqvist [Suède] ; Oskar Hansson [Suède] ; Lennart Minthon [Suède] ; Elisabet Londos [Suède] | Practical suggestions on how to differentiate dementia with Lewy bodies from Alzheimer's disease with common cognitive tests |
| 000A84 |
M. H. Nilsson [Suède] ; P. Hagell [Suède] | Freezing of Gait Questionnaire: validity and reliability of the Swedish version |
| 000B04 |
H. Nissinen [Finlande] ; M. Kuoppam Ki [Finlande] ; M. Leinonen [Suède] ; A. H. Schapira [Royaume-Uni] | Early versus delayed initiation of entacapone in levodopa‐treated patients with Parkinson’s disease: a long‐term, retrospective analysis |
| 000B30 |
D. Nyholm [Suède] ; R. Constantinescu [Suède] ; B. Holmberg [Suède] ; N. Dizdar [Suède] ; H. Askmark [Suède] | Comparison of apomorphine and levodopa infusions in four patients with Parkinson’s disease with symptom fluctuations |
| 000B34 |
E. Elgh ; M. Domellöf ; J. Linder ; M. Edström ; H. Stenlund [Suède] ; L. Forsgren | Cognitive function in early Parkinson’s disease: a population‐based study |
| 000B46 |
Leslie M. Shaw [États-Unis] ; Hugo Vanderstichele [Belgique] ; Malgorzata Knapik-Czajka [États-Unis] ; Christopher M. Clark [États-Unis] ; Paul S. Aisen [États-Unis] ; Ronald C. Petersen [États-Unis] ; Kaj Blennow [Suède] ; Holly Soares [États-Unis] ; Adam Simon [États-Unis] ; Piotr Lewczuk [Allemagne] ; Robert Dean [États-Unis] ; Eric Siemers [États-Unis] ; William Potter [États-Unis] ; Virginia M. Lee [États-Unis] ; John Q. Trojanowski [États-Unis] | Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects |
| 000B87 |
Ludvic Zrinzo [Suède, Royaume-Uni] ; Laurence V. Zrinzo [Suède, Royaume-Uni] ; Stephen Tisch [Suède, Royaume-Uni] ; Patricia Dowsey Limousin [Suède, Royaume-Uni] ; Tarek A. Yousry [Suède, Royaume-Uni] ; Farhad Afshar [Suède, Royaume-Uni] ; Marwan I. Hariz [Suède, Royaume-Uni] | Stereotactic localization of the human pedunculopontine nucleus: atlas-based coordinates and validation of a magnetic resonance imaging protocol for direct localization |
| 000C02 |
Johan Antonsson [Suède] ; Ola Eriksson [Suède] ; Patric Blomstedt [Suède] ; A Tommy Bergenheim [Suède] ; Marwan I Hariz [Suède, Royaume-Uni] ; Johan Richter [Suède] ; Peter Zsigmond [Suède] ; Karin Wrdell [Suède] | Diffuse reflectance spectroscopy measurements for tissue-type discrimination during deep brain stimulation |
| 000C07 |
Ana Mu Oz [France] ; Qin Li [France] ; Fabrizio Gardoni [France] ; Elena Marcello [France] ; Chuan Qin [France] ; Thomas Carlsson [France] ; Deniz Kirik [France] ; Monica Di Luca [France] ; Anders Björklund [France] ; Erwan Bezard [France, Suède] ; Manolo Carta [France, Suède] | Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of l-DOPA-induced dyskinesia |
| 000C80 |
Patrik Brundin [Suède] ; Jia-Yi Li [Suède] ; Janice L. Holton [Royaume-Uni] ; Olle Lindvall [Suède] ; Tamas Revesz [Royaume-Uni] | Research in motion: the enigma of Parkinson's disease pathology spread |
| 000D43 |
Marwan I. Hariz [Royaume-Uni, Suède] ; Stig Rehncrona [Suède] ; Niall P. Quinn [Royaume-Uni] ; Johannes D. Speelman [Pays-Bas] ; Carin Wensing [Pays-Bas] | Multicenter study on deep brain stimulation in Parkinson's disease: An independent assessment of reported adverse events at 4 years |
| 000D89 |
Owen A. Ross [États-Unis] ; Adam T. Braithwaite [États-Unis] ; Lisa M. Skipper [États-Unis] ; Jennifer Kachergus [États-Unis] ; Mary M. Hulihan [États-Unis] ; Frank A. Middleton [États-Unis] ; Kenya Nishioka [Japon] ; Julia Fuchs [Allemagne] ; Thomas Gasser [Allemagne] ; Demetrius M. Maraganore [États-Unis] ; Charles H. Adler [États-Unis] ; Lydie Larvor [France] ; Marie-Christine Chartier-Harlin [France] ; Christer Nilsson [Suède] ; J. William Langston [États-Unis] ; Katrina Gwinn [États-Unis] ; Nobutaka Hattori [Japon] ; Matthew J. Farrer [États-Unis] | Genomic investigation of α‐synuclein multiplication and parkinsonism |
| 000D99 |
D. Isacson [Suède] ; K. Bingefors [Suède] ; I. S. Kristiansen ; D. Nyholm [Suède] | Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion |
| 000E27 |
S. E. P Lhagen [Suède] ; M. Carlsson [Suède] ; E. Curman [Suède] ; J. W Linder [Suède] ; A. Granérus [Suède] | Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process? |
| 000E99 |
Andisheh Eslamboli [États-Unis] ; Marina Romero-Ramos [États-Unis] ; Corinna Burger [États-Unis] ; Tomas Bjorklund [États-Unis] ; Nicholas Muzyczka [États-Unis] ; Ronald J. Mandel [États-Unis] ; Harry Baker [États-Unis] ; Rosalind M. Ridley [États-Unis] ; Deniz Kirik [États-Unis, Suède] | Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain |
| 000F38 |
Maurice A. Curtis [Suède] ; Richard L. M. Faull [Nouvelle-Zélande] ; Peter S. Eriksson [Suède] | The effect of neurodegenerative diseases on the subventricular zone |
| 000F68 |
G. Waldemar [Danemark] ; B. Dubois [France] ; M. Emre [Turquie] ; J. Georges [Luxembourg (pays)] ; I. G. Mckeith [Royaume-Uni] ; M. Rossor [Royaume-Uni] ; P. Scheltens [Pays-Bas] ; P. Tariska [Hongrie] ; B. Winblad [Suède] | Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline |
| 000F87 |
A. Wallin [Suède] ; S. Ekberg [Suède] ; K. Lind [Suède] ; V. Milos [Suède] ; A. Granérus [Suède] ; G. Granerus [Suède] | Posterior cortical brain dysfunction in cognitively impaired patients with Parkinson’s disease – a rCBF scintigraphy study |
| 001220 |
Stephen B. Dunnett [Royaume-Uni] ; Anders Bjrklund [Suède] | Prospects for new restorative and neuroprotective treatments in Parkinson's disease |
| 001272 |
Andrea Carmine Belin [Suède] ; Marie Westerlund [Suède] ; Olof Sydow [Suède] ; Karin Lundströmer [Suède] ; Anna H Kansson [Suède] ; Hans Nissbrandt [Suède] ; Lars Olson [Suède] ; Dagmar Galter [Suède] | Leucine‐rich repeat kinase 2 (LRRK2) mutations in a Swedish Parkinson cohort and a healthy nonagenarian |
| 001308 |
Patric Blomstedt [Suède] ; Mazen Jabre ; Boulos-Paul Bejjani [Liban] ; Lars-Owe D. Koskinen [Suède] | Electromagnetic Environmental Influences on Implanted Deep Brain Stimulators |
| 001429 |
Karin Wirdefeldt [Suède] ; Margaret Gatz [Suède, États-Unis] ; Yudi Pawitan [Suède] ; Nancy L. Pedersen [Suède, États-Unis] | Risk and protective factors for Parkinson's disease: A study in Swedish twins |
| 001475 |
Anna H Kansson [Suède] ; Lars Westberg [Suède] ; Staffan Nilsson [Suède] ; Silvia Buervenich [Suède] ; Andrea Carmine [Suède] ; Björn Holmberg [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède] ; Bo Johnels [Suède] ; Elias Eriksson [Suède] ; Hans Nissbrandt [Suède] | Investigation of genes coding for inflammatory components in Parkinson's disease |
| 001476 |
Anna H Kansson [Suède] ; Lars Westberg [Suède] ; Staffan Nilsson [Suède] ; Silvia Buervenich [Suède] ; Andrea Carmine [Suède] ; Björn Holmberg [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède] ; Bo Johnels [Suède] ; Elias Eriksson [Suède] ; Hans Nissbrandt [Suède] | Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease |
| 001500 |
Anna Lena Törnqvist [Suède] ; Lucyna Schalén ; Stig Rehncrona [Suède] | Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson's disease treated with subthalamic deep brain stimulation |
| 001510 |
Poul Holm-Pedersen [Suède] ; Kirsten Avlund [Suède] ; Douglas E. Morse [Suède] ; Kaj Stoltze [Suède] ; Ralph V. Katz [Suède] ; Matti Viitanen [Suède] ; Bengt Winblad [Suède] | Dental Caries, Periodontal Disease, and Cardiac Arrhythmias in Community‐Dwelling Older Persons Aged 80 and Older: Is There a Link? |
| 001531 |
Björn Holmberg [Suède] ; Olle Corneliusson [Suède] ; Mikael Elam [Suède] | Bilateral stimulation of nucleus subthalamicus in advanced Parkinson's disease: No effects on, and of, autonomic dysfunction |
| 001704 |
Per-Arne Fall [Suède] ; Avin Saleh [Suède] ; Mats Fredrickson [Suède] ; Jan-Edvin Olsson [Suède] ; Ann-Kathrine Granérus [Suède] | Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐up |
| 001740 |
Andrea Carmine [Suède] ; Silvia Buervenich [Suède] ; Dagmar Galter [Suède] ; Erik G. Jönsson [Suède] ; Göran C. Sedvall [Suède] ; Lars Farde [Suède] ; J. Petter Gustavsson [Suède] ; Hans Bergman [Suède] ; Kodavali V. Chowdari [États-Unis] ; Vishwajit L. Nimgaonkar [États-Unis] ; Maria Anvret [Suède] ; Olof Sydow [Suède] ; Lars Olson [Suède] | NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits |
| 001747 |
Carl Rosenblad [Danemark] ; Biljana Georgievska [Suède] ; Deniz Kirik [Suède] | Long‐term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system |
| 001767 |
Marwan I. Hariz [Suède, Royaume-Uni] | From functional neurosurgery to “interventional” neurology: Survey of publications on thalamotomy, pallidotomy, and deep brain stimulation for Parkinson's disease from 1966 to 2001 |
| 001852 |
Luis Erik Clavería [Espagne] ; Jacinto Duarte [Espagne] ; Maria Dolores Sevillano [Espagne] ; Angel Pérez-Sempere [Espagne] ; Carmen Cabezas [Espagne] ; Fernanda Rodríguez [Espagne] ; Jesús De Pedro-Cuesta [Espagne, Suède] | Prevalence of Parkinson's disease in Cantalejo, Spain: A door‐to‐door survey |
| 001858 |
Julie Lotharius [Suède, Danemark] ; Patrik Brundin [Suède] | Pathogenesis of parkinson's disease: dopamine, vesicles and -synuclein |
| 001884 |
Julie Lotharius [Suède] ; Patrik Brundin [Suède] | Impaired dopamine storage resulting from α-synuclein mutations may contribute to the pathogenesis of Parkinson's disease |
| 001890 |
Maria Dolores Sevillano [Espagne] ; Jesús De Pedro-Cuesta [Espagne, Suède] ; Jacinto Duarte [Espagne] ; Luis Erik Clavería [Espagne] | Field validation of a method for population screening of parkinsonism |
| 001915 |
Anthony E. Lang [Canada] ; Hakan Widner [Suède] | Deep brain stimulation for Parkinson's disease: Patient selection and evaluation |
| 001939 |
M. Angela Cenci [Suède] ; Ian Q. Whishaw [Canada] ; Timothy Schallert [États-Unis] | Animal models of neurological deficits: how relevant is the rat? |
| 001965 |
Karin Wirdefeldt [Suède] ; Nenad Bogdanovic [Suède] ; Lisa Westerberg [Suède] ; Haydeh Payami [États-Unis] ; Martin Schalling [Suède] ; Geoffrey Murdoch [États-Unis] | Expression of α-synuclein in the human brain: relation to Lewy body disease |
| 001A35 |
Hjörtur Oddsson [Suède] ; H Kan Walfridsson [Suède] ; Nils Edvardsson [Suède] | Perception and Documentation of Arrhythmias after Successful Radiofrequency Catheter Ablation of Accessory Pathways |
| 001A53 |
Marianne Caap-Ahlgren [Suède] ; Ove Dehlin [Suède] | Insomnia and depressive symptoms in patients with Parkinson's disease |
| 001A57 |
Silvia Buervenich [Suède] ; Fengqing Xiang [Suède] ; Olof Sydow [Suède] ; Erik G. Jönsson [Suède] ; Göran C. Sedvall [Suède] ; Maria Anvret [Suède] ; Lars Olson [Suède] | Identification of four novel polymorphisms in the calcitonin/α‐CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression |
| 001A62 |
Shaowen Liu [Suède] ; Shiwen Yuan [Suède] ; Eva Hertervig [Suède] ; Ole Kongstad [Suède] ; S. Bertil Olsson [Suède] | Gender and atrioventricular conduction properties of patients with symptomatic atrioventricular nodal reentrant tachycardia and Wolff-Parkinson-White syndrome |
| 001B03 |
Björn Holmberg [Suède] ; Mika Kallio [Finlande] ; Bo Johnels [Suède] ; Mikael Elam [Suède] | Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes |
| 001B08 |
Shaowen Liu [Suède] ; S. Bertil Olsson [Suède] ; Eva Hertervig [Suède] ; Ole Kongstad [Suède] ; Shiwen Yuan [Suède] | Atrioventricular conduction: a determinant for the manifestation of ventricular preexcitation in patients with Wolff–Parkinson–White syndrome |
| 001B13 |
Bertil B. Fredholm [Suède] ; Giulia Arslan [Suède] ; Linda Halldner [Suède] ; Björn Kull [Suède] ; Gunnar Schulte [Suède] ; Ulrika Dén [Suède] ; Per Svenningsson [Suède] | Adenosine receptor signaling in vitro and in vivo |
| 001B15 |
Arvid Carlsson [Suède] | A Half‐Century of Neurotransmitter Research: Impact on Neurology and Psychiatry (Nobel Lecture) |
| 001B58 |
A. Björklund [Suède] ; D. Kirik [Suède] ; C. Rosenblad [Danemark] ; B. Georgievska [Suède] ; C. Lundberg [Suède] ; R. J. Mandel [États-Unis] | Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model |
| 001B76 |
Rolf Libelius [Suède] ; Folke Johansson [Suède] | Quantitative electromyography of the external anal sphincter in Parkinson's disease and multiple system atrophy |
| 001C64 |
Hans Forssberg [Suède] ; Páll E. Ingvarsson [Suède] ; Nobuaki Iwasaki [Suède] ; Roland S. Johansson [Suède] ; Andrew M. Gordon [États-Unis] | Action tremor during object manipulation in Parkinson's disease |
| 001D42 |
Claas Bentlage [Suède] ; Guido Nikkhah [Suède] ; Miles G. Cunningham [États-Unis] ; Anders Björklund [Suède] | Reformation of the Nigrostriatal Pathway by Fetal Dopaminergic Micrografts into the Substantia Nigra Is Critically Dependent on the Age of the Host |
| 001D48 |
A. Wallin [Suède] ; C. Jennersjö [Suède] ; A.-K Granérus [Suède] | Prevalence of dementia and regional brain syndromes in long-standing Parkinson's disease |
| 001D49 |
Jose M. Errea [Espagne] ; Jose R. Ara [Espagne] ; Carlos Aibar [Espagne] ; Jesus De Pedro-Cuesta [Espagne, Suède] | Prevalence of Parkinson's disease in lower Aragon, Spain |
| 001D75 |
Christian Winkler [Suède] ; Claas Bentlage [Allemagne] ; Guido Nikkhah [Allemagne] ; Madjid Samii [Allemagne] ; Anders Björklund [Suède] | Intranigral Transplants of GABA-Rich Striatal Tissue Induce Behavioral Recovery in the Rat Parkinson Model and Promote the Effects Obtained by Intrastriatal Dopaminergic Transplants |
| 001E64 |
A. Hansson [Suède] ; M. Holm [Suède] ; P. Blomstro M [Suède] ; R. Johansson [Suède] ; C. Lu Hrs ; J. Brandt ; S. B. Olsson [Suède] | Right atrial free wall conduction velocity and degree of anisotropy in patients with stable sinus rhythm studied during open heart surgery |
| 001E84 |
Steen Pehrson ; Jan Eskilsson ; Carl-Magnus Pripp ; Shiwen Yuan ; Per Blomström [Suède] | Improvement of Echocardiographic M‐Mode Detection of Ventricular Precontraction in the Wolff‐Parkinson‐White Syndrome by Transesophageal Atrial Pacing |
| 001F51 |
C. Rosenblad [Suède] ; A. Martinez-Serrano [Suède] ; A. Björklund [Suède] | Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease |
| 002040 |
Páll E. Ingvarsson [Suède] ; Andrew M. Gordon [Suède] ; Hans Forssberg [Suède] | Coordination of Manipulative Forces in Parkinson's Disease |
| 002061 |
Björn Johansson [Suède] ; Vasil Georgiev [Suède] ; Karin Lindström [Suède] ; Bertil B. Fredholm [Suède] | A1 and A2A adenosine receptors and A1 mRNA in mouse brain: effect of long-term caffeine treatment |
| 002067 |
Jesús De Pedro-Cuesta [Espagne, Suède] ; Gretar Gudmundsson [Islande] ; Victor Abraira [Espagne] ; Gunnar Gudmundsson [Islande] ; Arthur L Ve [Islande] ; Hrafn Tulinius [Islande] ; Jorge Veiga [Espagne] ; Javier Almazán [Espagne] ; Ingolf J. Petersen [Islande] | Whooping Cough and Parkinson's Disease |
| 002112 |
Per-Ame Fall [Suède] ; Olav Axelson [Suède] ; Mats Fredriksson [Suède] ; Gunilla Hansson [Suède] ; Björn Lindvall [Suède] ; Jan-Edvin Olsson [Suède] ; Ann-Kathrine Granérus [Suède] | Age-standardized incidence and prevalence of Parkinson's disease in a Swedish community |
| 002144 |
H Kan Nilsson [Suède] ; Olle Ekberg [Suède] ; Rolf Olsson [Suède] ; Bengt Hindfelt [Suède] | Quantitative assessment of oral and pharyngeal function in Parkinson's disease |
| 002149 |
Décio L. Eizirik [Suède] ; Peter Spencer [États-Unis] ; Glen E. Kisby [États-Unis] | Potential role of environmental genotoxic agents in diabetes mellitus and neurodegenerative diseases |
| 002167 |
A. Mouatt-Prigent [France] ; J. O. Karlsson [Suède] ; Yves Agid [France] ; E. C. Hirsch [France] | Increased m-calpain expression in the mesencephalon of patients with parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? |
| 002176 |
Christian Spenger [Suisse] ; K. Haque [Royaume-Uni] ; Lorenz Studer [Suisse] ; Ljudmila Evtouchenko [Suisse] ; Bendicht Wagner [Suisse] ; Beatrice Bühler [Suisse] ; Urban Lendahl [Suède] ; B. Dunnett [Royaume-Uni] ; W. Seiler [Suisse] | Fetal ventral mesencephalon of human and rat origin maintained in vitro and transplanted to 6-hydroxydopamine-lesioned rats gives rise to grafts rich in dopaminergic neurons |
| 002251 |
B. Johansson [Suède] ; B. B. Fredholm [Suède] | Further characterization of the binding of the adenosine receptor agonist [3H]CGS 21680 to rat brain using autoradiography |
| 002278 |
A. Fredriksson ; T. Archer [Suède] | Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice |
| 002292 |
Guido Nikkhah [Suède] ; J. Eberhard [Suède] ; M. Olsson [Suède] ; A. Björklund [Suède] | Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum |
| 002308 |
M. Matousek [Suède] ; C. Wikkelso [Suède] ; E. Blomsterwall [Suède] ; B. Johnels [Suède] ; G. Steg [Suède] | Motor performance in normal pressure hydrocephalus assessed with an optoelectronic measurement technique |
| 002316 |
O. Sydow [Suède] ; P. Hansson [Suède] ; D. Young [États-Unis] ; B. Meyerson [Suède] ; E-O. Backlund [Suède] ; T. Ebendal [Suède] ; L. O. Farnebo [Suède] ; R. Freedman ; B. Hamberger [Suède] ; B. Hoffer ; Seiger [Suède] ; I. Strömberq ; L. Olson | Long‐term beneficial effects of adrenal medullary autografts supported by nerve growth factor in Parkinson's disease |
| 002326 |
J. De Pedro-Cuesta [Suède, Espagne] ; I. J. Petersen ; L. Stawiarz [Suède] ; G. Gudmundsson ; G. Gudmundsson ; J. Almazán [Espagne] ; H. Tulinius [Islande] ; H. Johansson [Suède] | High levodopa use in periodically time‐clustered, Icelandic birth cohorts. A vestige of parkinsonism etiology? |
| 002327 |
R. James [Suède] ; Agneta Nordberg [Suède] | Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: Emphasis on Alzheimer's disease and Parkinson's disease |
| 002341 |
D. L. Eizirik [Suède] ; G. E. Kisby [États-Unis] | Cycad toxin-induced damage of rodent and human pancreatic β-cells |
| 002370 |
Giuseppe Biagini [Italie] ; Andrea Frasoldati [Italie] ; Kjell Fuxe [Suède] ; Luigi F. Agnati [Italie] | The concept of astrocyte-kinetic drug in the treatment of neurodegenerative diseases: Evidence for l-deprenyl-induced activation of reactive astrocytes |
| 002407 |
Ingrid Strömberg [Suède] ; Maria Johansson [Suède] | Re-initiated growth from mature ventral mesencephalon: an in oculo transplant study of nigrostriatal co-grafts |
| 002444 |
Göran Sedvall [Suède] ; Per Karlsson [Suède] ; Anders Lundin [Suède] ; Maria Anvret [Suède] ; Tetsuya Suhara [Suède] ; Christer Halldin [Suède] ; Lars Farde [Suède] | Dopamine D1 receptor number — a sensitive PET marker for early brain degeneration in Huntington's disease |
| 002463 |
G. Nikkhah [Suède] ; M. Olsson [Suède] ; J. Eberhard [Suède] ; C. Bentlage [Suède] ; M. G. Cunningham [États-Unis] ; A. Bjo Rklund [Suède] | A microtransplantation approach for cell suspension grafting in the rat parkinson model: A detailed account of the methodology |
| 002469 |
Björn Johansson [Suède] ; Vasil Georgiev [Suède] ; Fiona E. Parkinson [Suède] ; Bertil B. Fredholm [Suède] | The binding of the adenosine A2 receptor selective agonist [3H]CGS 21680 to rat cortex differs from its binding to rat striatum |
| 002518 |
G. Nikkhah [Suède] ; W.-M. Duan [Suède] ; U. Knappe [Allemagne] ; A. Jo Dicke [Allemagne] ; A. Bjo Rklund [Suède] | Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat parkinson model |
| 002605 |
L. Lorigados [Suède, Cuba] ; S. Söderström [Suède] ; T. Ebendal [Suède] | Two‐site enzyme immunoassay for βNGF applied to human patient sera |
| 002629 |
H Kan Eriksson [Suède] ; Joakim Tedroff [Suède] ; Karl- Ke Thuomas [Suède] ; Sten-Magnus Aquilonius [Suède] ; Per Hartvig [Suède] ; Karl-Johan Fasth [Suède] ; Peter Bjurling [Suède] ; Bengt L Ngström [Suède] ; Karl-Göran Hedström [Suède] ; Edith Heilbronn [Suède] | Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging |
| 002661 |
Olle Lindvall [Suède] | Prospects of transplantation in human neurodegenerative diseases |
| 002666 |
Kenneth C. Mccullough [Royaume-Uni, Suisse] ; Timothy U. Obi [Royaume-Uni, Nigeria] ; Hooshmand Shesberadaran [Royaume-Uni, Suède] | Identification of epitope(s) on the internal virion proteins of rinderpest virus which are absent from peste des petits ruminants virus |
| 002690 |
J. De Pedro-Cuesta [Suède, Espagne] ; L. Stawiarz [Suède] | Parkinson's disease incidence: magnitude, comparability, time trends |
| 002698 |
Shiwen Yuan [République populaire de Chine, Suède] ; Per Blomström [Suède] ; Steen Pehrson [Suède] ; S. Bertil Olsson [Suède] | Localization of cardiac arrhythmias: conventional noninvasive methods |
| 002702 |
M. Janson [Suède] ; K. Fuxe [Suède] ; M. Goldstein [États-Unis] ; Y. Deutch [États-Unis] | Hypertrophy of dopamine neurons in the primate following ventromedial mesencephalic tegmentum lesion |
| 002705 |
J. De Pedro-Cuesta [Suède] ; L. Stawiarz [Espagne] | Evaluation of how age modifies the risk for Parkinson's disease, based on stratified comparisons of descriptive data |
| 002706 |
S. W. Pederson [Suède] ; T. Eriksson [Suède] ; B. Öberg [Suède] | Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient |
| 002715 |
S. W. Pedersen [Suède] ; E. B Ckman [Suède] ; B. Öberg [Suède] | Characteristics of tetanic muscle contraction in Parkinson patients |
| 002723 |
P. Wang [États-Unis] ; K. Iqbal [États-Unis] ; G. Bucht [Suède] ; B. Winblad [Suède] ; M. Wisniewski [États-Unis] ; I. Grundke-Iqbal [États-Unis] | Alzheimer's disease: paired helical filament immunoreactivity in cerebrospinal fluid |
| 002816 |
O. Lindvall [Suède] ; A. Björklund [Suède] | Transplantation strategies in the treatment of Parkinson's disease: experimental basis and clinical trials |
| 002838 |
Lars G. Forssell [Suède] ; Roland Eklöf [Suède] ; Bengt Winblad [Suède] ; Lars Forssell [Suède] | Early Stages of Late Onset Alzheimer's Disease |
| 002839 |
Roser Cortés [Suisse, Suède] ; Montserrat Camps [Suisse, Espagne] ; Bianca Gueye [Suisse] ; Alphonse Probst [Suisse] ; Josém. Palacios [Suisse] | Dopamine receptors in human brain: autoradiographic distribution of D1 and D2 sites in Parkinson syndrome of different etiology |
| 002952 |
Abdu Adem [Suède] ; Agneta Nordberg [Suède] ; Gösta Bucht [Suède] ; Bengt Winblad [Suède] | Extraneural cholinergic markers in Alzheimer's and Parkinson's disease |
| 002989 |
P. Nilsson [Suède] ; F. Melsen [Danemark] ; J. Malmaeus [Suède] ; B. G. Danielson [Suède] ; L. Mosekilde [Danemark] | Relationships between calcium and phosphorus homeostasis, parathyroid hormone levels, bone aluminum, and bone histomorphometry in patients on maintenance hemodialysis |
| 002A19 |
Charlotte Sachs [Suède] ; Bo Berglund [Suède] ; Lennart Kaijser [Suède] | Autonomic cardiovascular responses in parkinsonism: effect of levodopa with dopa‐decarboxylase inhibition |
| 002A39 |
P. Slanina [Suède] ; Y. Falkeborn [Suède] ; W. Frech [Suède] ; A. Cedergren [Suède] | Aluminium concentrations in the brain and bone of rate fed citric acid, aluminium citrate or aluminium hydroxide |
| 002B24 |
C. Wikkels [Suède] ; C. Blomstrand [Suède] | Cerebrospinal fluid “specific” proteins in various degenerative neurological diseases |
| 002B41 |
C. J. Fowler [Irlande (pays)] ; L. Oreland [Suède] ; B. A. Callingham [Royaume-Uni] | The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J‐508: their properties and applications |
| 002C42 |
Henning Pakkenberg [Suède] ; Erik Birket-Smith [Suède] ; Erik Dupont [Suède] ; Erie Hansen [Suède] ; Bent Mikkelsen [Suède] ; Jan Presthus [Suède] ; Ilkka Rautakorpi [Suède] ; Eva Riman [Suède] ; Urpo K. Rinne [Suède] | PARKINSON'S DISEASE TREATED WITH SINEMET OR MADOPAR |
| 002C99 |
B. Forssman [Suède] ; S. Kihlstrand [Suède] ; L. Larsson [Suède] | AMANTADINE THERAPY IN PARKINSONISM |
